Researchers with the University of Cambridge for the first time leveraged human data to quantify the speed of various processes in the brain that lead to Alzheimer’s disease.
A study by The National Institutes for Quantum Science and Technology in Japan found that a supplement with seven specific amino acids called Amino LP7 appeared to slow brain degeneration and dementia development in mice.
President Donald Trump signed an Executive Order that ensures the U.S. government prioritizes delivery of Covid-19 vaccines to American citizens before sending them to other nations.
Shares of Evelo Biosciences were up more than 25 percent after the company announced the investigational asset EDP1815 will be included in the Phase II/III TACTIC-E COVID-19-focused clinical trial for conducted by Cambridge University Hospitals NHS Foundation Trust.
